lncRNA SNHG8 promotes aggressive behaviors of nasopharyngeal carcinoma via regulating miR-656-3p/SATB1 axis

被引:20
|
作者
Tian, Xiaoyan [1 ]
Liu, Yuehui [1 ]
Wang, Zhi [1 ]
Wu, Shuhong [1 ]
机构
[1] Nanchang Univ, Affiliated Hosp 2, Dept Otorhinolaryngol Head & Neck Surg, 1 Minde St, Nanchang 330006, Jiangxi, Peoples R China
关键词
SNHG8; Nasopharyngeal carcinoma; miR-656-3p; SATB1; CANCER CELLS; INVASION; PROLIFERATION; MIGRATION; GROWTH; SATB1;
D O I
10.1016/j.biopha.2020.110564
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Long non-coding RNA (lncRNA) has been proposed to regulate tumorigenesis, however, the role of small nucleolar RNA host gene 8 (SNHG8) in nasopharyngeal carcinoma (NPC) remains unclear. Methods: Levels of SNHG8 in NPC tissues and cells were analyzed with real-time quantitative PCR method. Cell counting kit-8 assay, colony formation assay, wound-healing assay, and transwell invasion assay were performed to detect cell viability, migration, and invasion. Luciferase activity assay and RIP assay were performed to explore relationships among SNHG8, microRNA-656 - 3p (miR-656 - 3p), and special AT-rich sequence-binding protein 1 (SATB1). Results: We found SNHG8 level was increased expression in NPC tissues and cells.In vitro assays revealed that SNHG8 stimulates NPC cell proliferation, colony formation, cell migration, and cell invasion. In vivo assay confirmed knockdown of SNHG8 could hamper tumor growth. Furthermore, we showed SNHG8 serves as a sponge for miR-656 - 3p to regulate SATB1 expression, and participated in NPC progression. Conclusions: In summary, our work indicated the importance of SNHG8 in NPC progression, which provided novel treatment methods for NPC.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] LncRNA SNHG15 acts as an oncogene in prostate cancer by regulating miR-338-3p/FKBP1A axis
    Zhang, Yuelong
    Zhang, Dahong
    Lv, Jia
    Wang, Shuai
    Zhang, Qi
    GENE, 2019, 705 : 44 - 50
  • [32] LncRNA SNHG16 promotes cell proliferation through miR-302a-3p/FGF19 axis in hepatocellular carcinoma
    Li, W.
    Xu, W.
    Song, J. S.
    Wu, T.
    Wang, W. X.
    NEOPLASMA, 2019, 66 (03) : 397 - 404
  • [33] LncRNA SNHG7 promotes glioma cells viability, migration and invasion by regulating miR-342-3p/AKT2 axis
    Cheng, Gaopeng
    Zheng, Jian
    Wang, Long
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2021, 131 (12) : 1190 - 1202
  • [34] LncRNA SNHG22 promotes gastric cancer progression by regulating the miR-101-3p/e2f2 axis
    Li, Zhen
    Lang, Zhiqiang
    Wang, Ting
    Qu, Guimei
    Sui, Wu
    Liu, Jing
    CELL CYCLE, 2023, 22 (03) : 347 - 360
  • [35] LncRNA SNHG3 promoted cell proliferation, migration, and metastasis of esophageal squamous cell carcinoma via regulating miR-151a-3p/PFN2 axis
    Ren, Tiejun
    Wang, Dingyi
    Gu, Jinjin
    Hou, Xiaozhen
    OPEN MEDICINE, 2022, 17 (01): : 1584 - 1598
  • [36] SNHG20 promotes the development of laryngeal squamous cell carcinoma via miR-342-3p/MTDH axis
    Xie, Zuozhong
    Xiang, Hong
    Li, Jingkun
    Zhang, Xiaowei
    Li, Wei
    Tan, Guolin
    HELIYON, 2022, 8 (08)
  • [37] LncRNA CASC19 Enhances the Radioresistance of Nasopharyngeal Carcinoma by Regulating the miR-340-3p/FKBP5 Axis
    Liu, Hongxia
    Chen, Qianping
    Zheng, Wang
    Zhou, Yuchuan
    Bai, Yang
    Pan, Yan
    Zhang, Jianghong
    Shao, Chunlin
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [38] LncRNA TDRG1 promotes the aggressiveness of gastric carcinoma through regulating miR-873-5p/HDGF axis
    Ma, Yan
    Xu, Xiu Lian
    Huang, Hai Ge
    Li, Yan Feng
    Li, Zhi Guo
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 121
  • [39] lncRNA NORAD promotes hepatocellular carcinoma progression via regulating miR-144-3p/SEPT2
    Tian, Qing
    Yan, Xiaodong
    Yang, Long
    Liu, Zirong
    Yuan, Zheyue
    Shen, Zhongyang
    Zhang, Yamin
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2020, 12 (05): : 2257 - 2266
  • [40] Silenced lncRNA SNHG14 restrains the biological behaviors of bladder cancer cells via regulating microRNA-211-3p/ESM1 axis
    Feng, Rui
    Li, Zhongxing
    Wang, Xing
    Ge, Guangcheng
    Jia, Yuejun
    Wu, Dan
    Ji, Yali
    Wang, Chenghao
    CANCER CELL INTERNATIONAL, 2021, 21 (01)